Dr. Surinder Kumar received his PhD degree from the Institute of Microbial Technology and the Jawaharlal Nehru University in India, where his studies focused on the identification and characterization of structurally and functionally important conserved vaccine targets in malaria. For his postdoctoral training, Dr. Kumar moved to the University of Michigan, initially to Dr. Sundeep Kalantry’s group, where he studied the process of X chromosome inactivation and, later to Dr. David Lombard’s laboratory, where his efforts addressed the role of sirtuin SIRT5 in mammalian diseases, particularly cancer. In 2018, he joined University of Michigan Pathology faculty as a Research Investigator. In 2022, Dr. Kumar was appointed by the University of Miami Miller School of Medicine to join its faculty as an Assistant Professor of research in the Department of Pathology & Experimental Medicine. His research focuses on the sirtuin family of deacylases and their relationships with aging, cancer, and metabolic disease. In addition, he is exploring the epigenetic mechanisms underlying cellular cadmium toxicity.
